Phenomex Inc 's

• CELL's Stock Performance relative to its Competitors

Beam Therapeutics Inc Share Performance -11.37% This Quarter

Beam Therapeutics Inc Profile Beam Therapeutics Inc's business model revolves around developing precision genetic medicines using base editing technology. They aim to address genetic diseases by making precise edits to a patient's DNA at the molecular level, providing potential treatments that are highly targeted and minimally invasive. More about Beam Therapeutics Inc 's Market Share

Bionano Genomics Inc Share Performance -23.84% This Year

Bionano Genomics Inc Profile Bionano Genomics Inc is a biotechnology company specializing in the development and commercialization of genomic analysis tools. Their business model revolves around offering proprietary genome imaging systems that provide high-resolution maps of DNA for researchers and clinicians to study genetic variations and diseases more effectively. More about Bionano Genomics Inc 's Market Share

Cellectis S a Share Performance -29.37% This Year

Cellectis S a Profile Cellectis S is a biotechnology company that operates using a business model focused on developing and commercializing gene editing technologies. They utilize a proprietary platform called TALEN® to modify genes for various applications in agriculture, healthcare, and biomanufacturing. By providing innovative solutions through gene editing, Cellectis aims to address critical challenges in these industries and create value for their customers and stakeholders. More about Cellectis S a 's Market Share

Crispr Therapeutics Ag Share Performance +5.34% This Year

Crispr Therapeutics Ag Profile CRISPR Therapeutics AG is a biopharmaceutical company focused on developing transformative gene-based medicines using its CRISPR/Cas9 gene-editing platform. They aim to leverage the potential of CRISPR to treat severe genetic diseases by directly modifying genes within the body's cells. The company collaborates with partners, conducts research and development of their therapeutics, and ultimately aims to bring their innovative treatments to market. More about Crispr Therapeutics Ag's Market Share

Ginkgo Bioworks Holdings Inc Share Performance -28.50% This Quarter

Ginkgo Bioworks Holdings Inc Profile Ginkgo Bioworks Holdings Inc is a biotechnology company that focuses on using genetic engineering to develop new organisms for various industries. Their business model includes partnering with companies to create custom-designed organisms for applications such as fragrance production, food and beverage, agriculture, and pharmaceuticals. They generate revenue through collaborations, licensing agreements, and providing access to their platform for organism design and development. More about Ginkgo Bioworks Holdings Inc 's Market Share

Sources: Phenomex Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on: Friday, August 14, 2026 8:46 AM
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Phenomex Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.